BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34579767)

  • 21. Wharton's jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata.
    Czarnecka A; Odziomek A; Murzyn M; Dubis J; Bagłaj-Oleszczuk M; Hryncewicz-Gwóźdź A
    Adv Clin Exp Med; 2021 Feb; 30(2):211-218. PubMed ID: 33636057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Platelet Lysate Supports Efficient Expansion and Stability of Wharton's Jelly Mesenchymal Stromal Cells via Active Uptake and Release of Soluble Regenerative Factors.
    Cañas-Arboleda M; Beltrán K; Medina C; Camacho B; Salguero G
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32877987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
    Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
    Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal Stem Cells Derived from Wharton's Jelly Can Differentiate into Schwann Cell-Like Cells and Promote Peripheral Nerve Regeneration in Acellular Nerve Grafts.
    Choi SJ; Park SY; Shin YH; Heo SH; Kim KH; Lee HI; Kim JK
    Tissue Eng Regen Med; 2021 Jun; 18(3):467-478. PubMed ID: 33515168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus.
    Liu X; Zheng P; Wang X; Dai G; Cheng H; Zhang Z; Hua R; Niu X; Shi J; An Y
    Stem Cell Res Ther; 2014 Apr; 5(2):57. PubMed ID: 24759263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.
    Hendijani F; Javanmard SH; Sadeghi-aliabadi H
    Tissue Cell; 2015 Jun; 47(3):229-34. PubMed ID: 25779671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
    Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
    Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton's jelly-derived mesenchymal stem cells (WJ-MSC).
    Zavala G; Prieto CP; Villanueva AA; Palma V
    Stem Cell Res Ther; 2017 Sep; 8(1):203. PubMed ID: 28962669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Benefits and Hazards of Intravitreal Mesenchymal Stem Cell (MSC) Based-Therapies in the Experimental Ischemic Optic Neuropathy.
    Wen YT; Ho YC; Lee YC; Ding DC; Liu PK; Tsai RK
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
    Shi Q; Gao J; Jiang Y; Sun B; Lu W; Su M; Xu Y; Yang X; Zhang Y
    Stem Cell Res Ther; 2017 Nov; 8(1):246. PubMed ID: 29096715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preeclampsia enhances neuroglial marker expression in umbilical cord Wharton's jelly-derived mesenchymal stem cells.
    Joerger-Messerli M; Brühlmann E; Bessire A; Wagner A; Mueller M; Surbek DV; Schoeberlein A
    J Matern Fetal Neonatal Med; 2015 Mar; 28(4):464-9. PubMed ID: 24803009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
    Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
    Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study.
    Kabataş S; Civelek E; İnci Ç; Yalçınkaya EY; Günel G; Kır G; Albayrak E; Öztürk E; Adaş G; Karaöz E
    Cell Transplant; 2018 Oct; 27(10):1425-1433. PubMed ID: 30203688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering.
    Zhang L; Zhao YH; Guan Z; Ye JS; de Isla N; Stoltz JF
    Biomed Mater Eng; 2015; 25(1 Suppl):137-43. PubMed ID: 25538064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial.
    Saleh M; Vaezi AA; Aliannejad R; Sohrabpour AA; Kiaei SZF; Shadnoush M; Siavashi V; Aghaghazvini L; Khoundabi B; Abdoli S; Chahardouli B; Seyhoun I; Alijani N; Verdi J
    Stem Cell Res Ther; 2021 Jul; 12(1):410. PubMed ID: 34271988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
    Borys-Wójcik S; Brązert M; Jankowski M; Ożegowska K; Chermuła B; Piotrowska-Kempisty H; Bukowska D; Antosik P; Pawelczyk L; Nowicki M; Jeseta M; Kempisty B
    J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):119-123. PubMed ID: 30729769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
    Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regenerative potential of Wharton's jelly-derived mesenchymal stem cells: A new horizon of stem cell therapy.
    Abbaszadeh H; Ghorbani F; Derakhshani M; Movassaghpour AA; Yousefi M; Talebi M; Shamsasenjan K
    J Cell Physiol; 2020 Dec; 235(12):9230-9240. PubMed ID: 32557631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.